{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:53:45Z","timestamp":1790520825528,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC011585 04"],"award-info":[{"award-number":["ZIA BC011585 04"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.chembiol.2018.12.006","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T10:57:20Z","timestamp":1545303440000},"page":"1437-1438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting Mammalian Translational Inhibition with Tetracyclines"],"prefix":"10.1016","volume":"25","author":[{"given":"Robert E.","family":"Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John S.","family":"Schneekloth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2018.12.006_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pupt.2012.06.010","article-title":"Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cells","volume":"25","author":"Bensman","year":"2012","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.chembiol.2018.12.006_bib2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","article-title":"The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit","volume":"103","author":"Brodersen","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2018.12.006_bib3","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in\u00a0AIDS-related Kaposi\u2019s sarcoma: an AIDS Malignancy Consortium Study","volume":"24","author":"Dezube","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.chembiol.2018.12.006_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2010.11.003","article-title":"Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers","volume":"63","author":"Lokeshwar","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chembiol.2018.12.006_bib5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.chembiol.2018.09.010","article-title":"Tetracyclines modify translation by targeting key human rRNA substructures","volume":"25","author":"Mortison","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.12.006_bib6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.chembiol.2018.12.006_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2001.19.2.584","article-title":"Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer","volume":"19","author":"Rudek","year":"2001","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.chembiol.2018.12.006_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrd.2018.93","article-title":"Principles for targeting RNA with drug-like small molecules","volume":"17","author":"Warner","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2018.12.006_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618304446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618304446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T01:38:03Z","timestamp":1764812283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945618304446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2451945618304446"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.12.006","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Mammalian Translational Inhibition with Tetracyclines","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.09.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}